Q1 2022

Filed May 20, 2022 · 10-Q · 50 days after period end · 0001493152-22-014637

Q1 2022 · 10-Q

Revenue

$13.76K

−37.5% vs Q1 2021

Net Income

$5.01M

N/M vs Q1 2021

EPS Diluted

$0.00

— vs Q1 2021

Gross Profit$7,792−52.5%

Operating Income

Same quarter

Metric	Q1 2022	Q1 2021	Q1 2020	Q1 2019
Revenue	$13.76K	$22.02K	$17.12K	$41.32K
Net Income	$5.01M	-$34.02M	$2.18M	-$400.44K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR